These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38271697)

  • 21. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
    Shaikh S; Ram DB; Tanveer S; Talpur A
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
    Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
    J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
    Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First molecular epidemiological study of hepatitis B and D in individuals infected with human T-lymphotropic virus 1/2 from Argentina.
    Pataccini G; Berini CA; Pedrozo WR; Biglione MM; Delfino CM
    J Med Virol; 2021 Jun; 93(6):3995-3998. PubMed ID: 32725912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBV S antigen evolution in the backdrop of HDV infection affects epitope processing and presentation.
    Sajjad M; Ali S; Baig S; Sharafat S; Khan BA; Khan S; Mughal N; Abidi SH
    J Med Virol; 2021 Jun; 93(6):3714-3729. PubMed ID: 33289144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of hepatitis B and Delta virus strains that spread in the Mediterranean North East Coast of Tunisia.
    Yacoubi L; Brichler S; Mansour W; Le Gal F; Hammami W; Sadraoui A; Ben Mami N; Msaddek A; Cheikh I; Triki H; Gordien E
    J Clin Virol; 2015 Nov; 72():126-32. PubMed ID: 26513762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon.
    Melo Da Silva E; Kay A; Lobato C; Muwonge R; Zoulim F; Brites C; Parana R; Trepo C
    J Med Virol; 2019 Jun; 91(6):1081-1086. PubMed ID: 30695106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.
    Mederacke I; Filmann N; Yurdaydin C; Bremer B; Puls F; Zacher BJ; Heidrich B; Tillmann HL; Rosenau J; Bock CT; Savas B; Helfritz F; Lehner F; Strassburg CP; Klempnauer J; Wursthorn K; Lehmann U; Manns MP; Herrmann E; Wedemeyer H
    J Hepatol; 2012 Jan; 56(1):115-22. PubMed ID: 21762665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
    Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
    PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis.
    Hoan NX; Hoechel M; Tomazatos A; Anh CX; Pallerla SR; Linh LTK; Binh MT; Sy BT; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Meyer CG; Song LH; Velavan TP
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immune recognition and modulation in hepatitis D virus infection.
    Jung S; Altstetter SM; Protzer U
    World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.
    Battegay M; Simpson LH; Hoofnagle JH; Sallie R; Di Bisceglie AM
    J Med Virol; 1994 Dec; 44(4):389-92. PubMed ID: 7897369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a dual channel detection system for pan-genotypic simultaneous quantification of hepatitis B and delta viruses.
    Liu Y; Maya S; Carver S; O'Connell AK; Tseng AE; Gertje HP; Seneca K; Nahass RG; Crossland NA; Ploss A
    Emerg Microbes Infect; 2024 Dec; 13(1):2350167. PubMed ID: 38687692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
    Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2022 Aug; 6(8):1870-1880. PubMed ID: 35368148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
    Ricco G; Popa DC; Cavallone D; Iacob S; Salvati A; Tabacelia D; Oliveri F; Mascolo G; Bonino F; Yuan Q; Xia NS; Gheorghe L; Brunetto MR
    J Viral Hepat; 2018 Aug; 25(8):911-919. PubMed ID: 29577518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.